Tag: Metastatic Breast Cancer

Washington: The US Food and Drug Administration (FDA) has approved a new drug to treat patients with advanced or metastatic breast cancer that has progressed after taking prior treatment. The drug — Verzenio (abemaciclib) — can be used for treatment of people with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2) — negative advanced […]